Study illuminates how the plague bacteria causes disease

September 07, 2006

The bacteria responsible for the plague and some forms of food poisoning "paralyze" the immune system of their hosts in an unexpected way, according to a new study in the September 8, 2006 issue of the journal Cell, published by Cell Press.

The researchers found that these bacteria, which belong to the genus Yersinia, harbor a protein that mimics an apparently unrelated mammalian enzyme. That copycat protein blocks host cells' capacity to change shape and move, abilities important for cells of the immune system to track down and "eat" foreign invaders, the researchers explained.

The discovery marks the second way in which this protein, called YpkA, compromises the immune system. Earlier studies suggested that another portion of YpkA--which may have been derived from a mammalian enzyme and later co-opted by Yersinia--has activity that also influences cell shape by a separate, though incompletely understood mechanism.

The findings offer important new insight into the factors that lend Yersinia their ability to spawn disease, the researchers said. The results might also contribute to new strategies for fighting the bug.

"Yersinia injects several virulence factors into its host," said C. Erec Stebbins of Rockefeller University. "If we can discover which ones are critical, we might identify the pathogen's Achilles heel--an attractive target for antibacterial or anti-virulence compounds."

"We were quite excited to see such a critical and unexpected factor in the virulence of Yersinia--a bacteria historically responsible for some of the worst diseases," he added. Although improvements in sanitation have eliminated acute problems from diseases caused by Yersinia, concerns remain about the possibility that an untreatable strain might arise or that the bacteria might come into use as a biological weapon, he said.

Nearly 200 million people are estimated to have died in the plague epidemics that devastated the ancient world, the researchers said. The successful weaponization of plague in the former Soviet Union bioweapons program also made the pathogen a primary biodefense concern. Additional medical concerns have arisen from the evolution of multidrug-resistant strains of the plague bacterium found in patients from several locations.

The plague bacterium Yersinia pestis is closely related to Y. enterocolitica and Y. pseudotuberculosis, which are food-borne agents that cause inflammation of the stomach and intestines. All Yersinia bacteria have a virulence plasmid, which is necessary to cause disease. Plasmids are extra DNA molecules frequently found in bacteria containing genes that can be passed from one bacterial strain to another and that may confer an evolutionary advantage, such as antibiotic resistance.

In the case of Yersinia, the plasmid harbors numerous genes, including a large number that contribute to the ability of diverse pathogens to deliver virulence factors into host cells. One of these genes is YpkA, a protein with multiple domains, including one closely related to an enzyme, a type of kinase, not typically found in bacteria. Earlier studies found that mutations that eliminate this activity reduce but do not eliminate YpkA's ability to disrupt cell shape by modifying their cytoskeletal support system.

In the current study, the researchers solved the high-resolution crystal structure of a second YpkA domain, the "Rho-GTPase binding domain" along with the host protein, "Rac1," with which it interacts.

"The Yersinia structure was doing things to Rac1 that the host proteins normally do," Stebbins said, suggesting that the domain acted as a mimic.

Further examination confirmed the domain to be a mimic of mammalian "guanidine nucleotide dissociation inhibitor" (GDI) proteins with a critical role in the bacteria's ability to disrupt cell structure. The domain paralyzes cells by acting as an "off-switch" for host proteins involved in modifying cell shape, Stebbins said.

Mutations that prevented the bacterial proteins' interaction with the host protein significantly impaired YpkA's ability to disrupt the cytoskeleton. Moreover, a mutant strain of Y. pseudotuberculosis that lacked the GDI activity caused significantly fewer problems for infected mice compared to normal bacteria.

"Earlier studies that focused only on the protein's kinase activity had missed half the picture," Stebbins said. "The GDI domain seems to have an even bigger effect on host cells in culture, and a significant impact on virulence."

The results also add to broader themes in the evolution of bacterial diseases, the researchers added.

"It is becoming increasingly clear that a common strategy used by bacterial pathogens to manipulate host cell biology is the mimicry of their own biochemical processes," Stebbins said.
-end-
The researchers include Gerd Prehna and C. Erec Stebbins of Rockefeller University in New York, NY; Maya I. Ivanov and James B. Bliska and of Stony Brook University in Stony Brook, NY.

This work was funded in part by research funds to C.E.S. from the Rockefeller University and PHS grants 1U19AI056510 (to C.E.S) and RO1AI433890 (to J.B.B) from the National Institute of Allergy and Infectious Diseases.

Prehna et al.: "Virulence in Yersinia Is Dependent on a Bacterial Mimic of Host Rho-Family Nucleotide Dissociation Inhibitors." Publishing in Cell 126, 869-880, September 8, 2006. DOI 10.1016/j.cell.2006.06.056 http://www.cell.com

Cell Press

Related Immune System Articles from Brightsurf:

How the immune system remembers viruses
For a person to acquire immunity to a disease, T cells must develop into memory cells after contact with the pathogen.

How does the immune system develop in the first days of life?
Researchers highlight the anti-inflammatory response taking place after birth and designed to shield the newborn from infection.

Memory training for the immune system
The immune system will memorize the pathogen after an infection and can therefore react promptly after reinfection with the same pathogen.

Immune system may have another job -- combatting depression
An inflammatory autoimmune response within the central nervous system similar to one linked to neurodegenerative diseases such as multiple sclerosis (MS) has also been found in the spinal fluid of healthy people, according to a new Yale-led study comparing immune system cells in the spinal fluid of MS patients and healthy subjects.

COVID-19: Immune system derails
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.

Immune cell steroids help tumours suppress the immune system, offering new drug targets
Tumours found to evade the immune system by telling immune cells to produce immunosuppressive steroids.

Immune system -- Knocked off balance
Instead of protecting us, the immune system can sometimes go awry, as in the case of autoimmune diseases and allergies.

Too much salt weakens the immune system
A high-salt diet is not only bad for one's blood pressure, but also for the immune system.

Parkinson's and the immune system
Mutations in the Parkin gene are a common cause of hereditary forms of Parkinson's disease.

How an immune system regulator shifts the balance of immune cells
Researchers have provided new insight on the role of cyclic AMP (cAMP) in regulating the immune response.

Read More: Immune System News and Immune System Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.